• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Early results favor laparoscopic sleeve gastrectomy over gastric bypass

bys25qthea
October 24, 2013
in Chronic Disease, Gastroenterology, Surgery
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Laparoscopic sleeve gastrectomy (LSG) is a shorter procedure on average compared to laparoscopic roux-en-Y gastric bypass (LRYGB) and may exhibit a lower complication rate. 

2. At 1 year follow-up, the two operations were similarly effective with respect to weight loss, recovery from comorbidities and quality of life, but GERD remission and new-onset was more common after LSG. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Authors present a 1-year interim analysis of a multicenter Swiss RCT comparing LSG with LRYGB. They report shorter operating time with LSG and an almost-significant reduction in the 30-day complication rate (p=0.067), a trend that is consistent with prior studies. This trial was well-designed with four participating bariatric centers and 100% 1-year follow-up rate. About half of study participants completed 2-year follow-up and only 70 out of 217 patients returned for 3-year follow-up at the time point of analysis. Therefore some preliminary conclusions drawn in the study may be premature. Additionally, one of the main conclusions regarding complication rates has not yet reached statistical significance.

Click to read the study in the Annals of Surgery

RELATED REPORTS

Obesity associated with higher early-onset cancer risk among young Korean adults

Once-monthly bofanglutide maintained weight loss over 24 weeks in topline phase 3 results

Relevant Reading: Bariatric Surgery: A Systematic Review and Meta-analysis

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [randomized control trial]: This study randomized 217 bariatric surgery patients across four medical centers to either laparoscopic sleeve gastrectomy (LSG) or laparoscopic roux-en-Y gastric bypass (LRYGB). The results presented here are from an interim analysis at 1 year with excess BMI loss as the primary endpoint. Patients were assessed four times within the first year and will be followed yearly thereafter. Other items assessed were eating behavior, comorbidities, anthropometric parameters, clinical parameters and quality of life. Prior to surgery, patients’ BMI ranged between 35 and 61, and the two groups were similar in terms of demographic characteristics, eating behavior and comorbidities. LRYGB operations lasted longer than LSG by a mean of about 21 minutes (p=0.003). In the LSG group 34% of patients underwent additional procedures such as cholecystectomies, compared to 24% in the LRYGB group, although this was not a significant difference (p=0.09). The difference in 30-day complication rates were also not significant between the two groups (8.4% LSG vs. 17.2% LRYGB p=0.067) and the difference in major complication rates was not significant. Weight loss and excessive BMI loss were similarly not significantly different between LSG and LRYGB. Comorbidity remission and improvement were also similar in the two groups, however patients who underwent sleeve gastrectomy were at a higher risk of new-onset GERD (12.5% vs. 4%, p=0.12) as well as returning GERD (75% vs. 50% p=0.008).

By Asya Ofshteyn and Allen Ho

More from this author: Frey procedure may yield better outcomes in chronic pancreatitis, Radial artery harvest comparable to saphenous vein harvest for cardiac bypass, RAS mutation linked with survival in metastatic colorectal cancer, Bariatric surgery linked to reversal of diabetes, Postoperative readmission rates correlated with length of stay and ASA class

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: gastric bypassobesitysleeve gastrectomy
Previous Post

A new genetic test for susceptibility to dapsone hypersensitivity syndrome

Next Post

Further evidence of link between antithyroid drugs in pregnancy and birth defects

RelatedReports

Obesity measurement collage: a bathroom scale with a blank dial, a loose cloth measuring tape, an apple and a pear
Chronic Disease

Obesity associated with higher early-onset cancer risk among young Korean adults

November 13, 2026
Obesity treatment collage: a bathroom scale with a blank dial, a coiled tape measure and a bowl of fresh vegetables
2MM Trial Briefs

Once-monthly bofanglutide maintained weight loss over 24 weeks in topline phase 3 results

November 5, 2026
Surgical care collage: an operating light over a draped table, a tray with a surgical cap and mask, and a closed case
Imaging and Intervention

Ring-augmented one-anastomosis gastric bypass may not improve weight loss compared to conventional one-anastomosis gastric bypass

June 10, 2026
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Weekly Rewinds

2 Minute Medicine Rewind June 8, 2026

June 8, 2026
Next Post
Further evidence of link between antithyroid drugs in pregnancy and birth defects

Further evidence of link between antithyroid drugs in pregnancy and birth defects

HIV-infected infant potentially cured with antiretroviral therapy

HIV-infected infant potentially cured with antiretroviral therapy

Classics Series, Landmark Trials in Medicine

The PLATO trial: Ticagrelor vs clopidogrel for ACS [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
  • CDC reports 5,412 confirmed measles cases in the United States in 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.